The successful development of nanomaterials illustrates the considerable interest in the development of new molecular probes for medical diagnosis and imaging. Substantial progress was made in the synthesis protocol and characterization of these materials, whereas toxicological issues are sometimes incomplete. Nanoparticlebased contrast agents (CAs) tend to become efficient tools for enhancing medical diagnostics and surgery for a wide range of imaging modalities. The multimodal nanoparticles (NPs) are much more efficient than the conventional molecular-scale CAs. They provide new abilities for in vivo detection and enhanced targeting efficiencies through longer circulation times, designed clearance pathways, and multiple binding capacities. Properly protected, they can safely be used for the fabrication of various functional systems with targeting properties, reduced toxicity, and proper removal from the body. This review mainly describes the advances in the development of mono-to multimodal NPs and their in vitro and in vivo relevant biomedical applications ranging from imaging and tracking to cancer treatment. Besides the specific applications for classical imaging (magnetic resonance imaging, positron emission tomography, computed tomography, ultrasound, and photoacoustic imaging), the less common imaging techniques such as terahertz molecular imaging (THMI) or ion beam analysis (IBA) are mentioned. The perspectives on the multimodal theranostic NPs and their potential for clinical advances are also mentioned.
Introduction
Nanoparticles (NPs) as CAs tend to become standard practice in the field of imaging, for both bioimaging and medical imaging [1] . They are used to improve the enhancement of the image contrast compared to the molecular species and improve the visibility of the features that would otherwise be difficult to detect. They go on receiving considerable attention in this field for their potential as CAs [2 -9] , offering many advantages compared to the more conventional chemical agents such as greater biocompatibility and reduced toxicity [8, 10 -13] . Noninvasive imaging and minimally invasive in vivo bioimaging techniques are, of course, the most valuable tools for clinical diagnostics. The clinical imaging modalities generally include complementary techniques [14] such as optical imaging [15 -23] , magnetic resonance imaging (MRI) [24 -27] , computed tomography (CT) [28] , ultrasound imaging (USI) [29 -33] , positron emission tomography (PET) [34 -37] , and single photon emission CT (SPECT) [38 -40] . Other techniques are also scrutinized, for example, multiphoton plasmon resonance microscopy [41] , optical coherence tomography (OCT) [42] , surface-enhanced Raman spectroscopy (SERS) [15, 43 -47] , and diffuse optical spectroscopy [48] . Some of these techniques enable entire-organism anatomical imaging (e.g., MRI or PET), and others provide more specific molecular imaging (e.g., optical fluorescence or USI) at subcellular resolution. The combination of these different tools should allow a better early stage cancer diagnosis, guided stem cell therapies, drug delivery, pathogen detection, gene therapy, image-guided surgery, and cancer staging [49] , in addition to many other clinically relevant procedures, diagnostics, and therapies.
To help in improving these technique resolutions, NPs emerge as very powerful probes for both in vivo imaging in medical and biological diagnostics. Several NP-based CAs have helped in generating breakthroughs compared to the common CAs improving their properties and detection limits, in a broad array of imaging modalities. The specifications of an ideal NP CA are numerous. It should exhibit colloidal stability in biological in vivo media, nondependence on the solvent polarity, ionic strength, pH, or temperature. Other properties such as limited nonspecific binding, resistance to reticuloendothelial system (RES) uptake, and easy clearance mechanisms are also required. High sensitivity and selectivity for the target (e.g., antigen, cell, and tissue) with good contrast quality [high signal-tonoise ratio (SNR)] and sufficiently long blood circulation times are also mandatory. In other words, this NP should have the adapted long-term quantitative imaging at low doses and be safely cleared from the body after imaging completion.
In Table 1 , besides the characteristics of the most commonly used in vivo imaging modalities in the clinical field are also some more recent ones such as terahertz molecular imaging (THMI), particle-induced X-ray emission (PIXE), Rutherford backscattering spectrometry (RBS), and scanning transmission ion microscopy (STIM). Each type of in vivo imaging technique has its own advantages and limitations, which include spatial and/or temporal resolution, sensitivity, SNR, penetration depth in tissue, and quantitative accuracy.
A close look at the literature reveals that, basically, there are some types of NPs that always appear as CAs: metal NPs (mostly gold) and metal oxide NPs. They appear either as active agents, such as iron oxide in MRI, for example, or as carriers of the active agent like silica NPs.
In this review, our aim is to give a state-of-the-art presentation of the most recent works on the subject including the most recent techniques and to categorize these NPs according to their field of activities: MRI, near-infrared fluorescence (NIRF) imaging, PET, CT, ultrasound (US), photoacoustic imaging (PAI) and THMI. Table 1 highlights the current NP-based contrast labels for each of these techniques. The multifunctional/multimodal NPs and theranostic NPs will be highlighted; their potential for clinical use will also be discussed. The reader can also get information on numerous imaging techniques in various reviews [14, 16, 28, 54 -56] .
Magnetic resonance imaging (MRI)
MRI is typically the noninvasive and nonionizing imaging method that provides both physiological and pathological information about living tissue, usually by measuring water proton relaxation rates. MRI offers a high soft tissue contrast especially with CAs and provides deep tissue imaging with high spatial resolution ( ∼ 50 μ m). The major drawback of this technique is its low sensitivity requiring the use of these CAs whose role is to alter the relaxation processes. CAs are divided into two classes: those that increase the T 1 signal in T 1 -weighted images (so-called positive CAs, giving a bright contrast) and those that reduce the T 2 signal in T 2 -weighted images (so-called negative CAs, leading to a dark contrast). The effectiveness of a particular probe is defined by its longitudinal ( r 1 ) and transverse ( r 2 ) relaxivities. T 2 agents are not so convenient for diagnosis because they provide a dark contrast, which is not so easy for the clinicians to interpret. In contrast, the signal produced by T 1 (paramagnetic) CAs can easily be detected with high spatial resolution.
T 1 NP-based contrast agents
Three important requirements for the design of highly sensitive paramagnetic NPs have been identified: (i) a large number of labile water molecules coordinated to the metal, (ii) an optimum residence lifetime at the metal site, and (iii) a slow tumbling motion of the NP containing the CA [57] . To fulfill these requirements, a well-known T 1 CA, Gd(III), has been incorporated into various nanomaterials, for example, silica and perfluorocarbon NPs, carbon nanotubes [58] , carbon nanodots [59] , and nanodiamonds [60] , which all exhibit a high MR contrast because of a high payload of gadolinium ions and a slow tumbling motion of the particles. For a Gd(III) complex attached to the nanodiamonds, a tenfold relaxivity increase was observed compared with the monomeric Gd(III) complex. Gadolinium chelates were grafted on to gold for dual imaging [61] and mesoporous silica NPs [62, 63] , leading to a high local concentration of CA compared to the molecular complexes. They were associated with the other lanthanides to provide particles capable of dual imaging [64, 65] , with drug for therapeutic function [66] or with gene in microglial cells for therapy [67] .
However, the gadolinium loading on these systems strongly depends on the number of the anchoring sites available on the surface of the NPs even if Gd(III) could also recently be dispersed in a carbon matrix [59] . A way to solve this problem relies in the synthesis of Gdbased paramagnetic NPs [68] , such as Ln 2 O 3 , GdF 3 , and GdPO 4 [26, 69, 70] , which yield high magnetic moments because of the abundance of paramagnetic ions on their surfaces.
The transition metal oxide (MnO) NPs, Manganese (Mn), have recently been developed by various groups for T 1 -contrast imaging of brain tumors [71] , in addition to the liver and kidney [58, 72] . The hollow MnO NPs could also Table 1 List of commonly used bioimaging techniques (partly adapted from Refs [50] and [51] High spatial resolution High Low sensitivity, cannot follow many labels, time consuming PET NPs incorporating radioisotopes (e.g., 18 F, 11 C, 64 Cu, 124 
I)
Positron from radionuclides 1 -2 mm carry drug mole cules in their cavities for simultaneous imaging and therapy applications [73] . Silica has been recognized as a good candidate for a coating material because it is relatively biocompatible and resistant to biodegradation [74, 75] . Among others, mesoporous silica-coated hollow MnO NPs (HMnO@mSiO 2 ) have been synthesized and characterized. These NPs show a significantly higher r 1 relaxivity than other existing manganese oxide NP-based CAs. The porous SiO 2 coating enables water exchange across the shell, and the high surface-to-volume ratio of the hollow structure increases the water accessibility to the manganese core and, consequently, enhances T 1 contrast. The HMnO@mSiO 2 NPs also showed a potential MRI cell tracking using the positive contrast [75] .
With relaxivities that depend on the biological environment, " smart " T 1 MR probes that respond to their surroundings have been pursued extensively [57] . This class of probe primarily consists of Gd(III)-based complexes; incorporation of these smart probes into the NPs will further enhance their efficiency in molecular imaging applications. Very recently, the use of an improved hydrolysis method of inorganic salts assisted by incubation in a water bath led to water-soluble extremely small-sized metal-iron oxide NPs (IONPs), iron-oxide based NPs: MFe 2 O 4 (ESIONs) (M = Fe, Zn, Ni) NPs with average sizes of 4-5 nm [76, 77] . The r 1 relaxivities and the r 2 /r 1 ratios of these NPs were more than 5 and < 3, respectively, which indicated that they were good candidates as T 1 -weighted MRI CAs. As an example, the γ -Fe 2 O 3 ESIONs were synthesized by controlled thermal decomposition of iron-oleate complex in the presence of oleyl alcohol via a heat-up process. These ESIONs revealed a maghemite crystal structure with a magnetization much smaller than that of 12 nm-sized IONPs due to their small magnetic moment and a spin-canting effect. The ESIONs have a large number of surface Fe 3 + ions with 5 unpaired electrons exhibiting high r 1 relaxivities of > 4.7 m m -1 s -1 and low r 2 / r 1 ratios of < 6.2. Their high r 1 relaxivity and long blood circulation time enabled the high-resolution blood pool T 1 -weighted MR imaging of various blood vessels with sizes down to 0.2 mm. With their low toxicity, high r 1 relaxivity, and long blood half-life, they could become the new T 1 MRI CAs for the various clinical applications including the diagnosis of myocardial infarction, renal failure, atherosclerotic plaque, thrombosis, and angiogenesis of tumor cells.
T 2 NP-based CAs
Besides these lanthanide derivatives, magnetic NP-based probes have been developed for MRI to achieve a high tissue contrast and to improve imaging sensitivity. The most popular material studied for T 2 (superparamagnetic) CAs is based on IONPs (maghemite and magnetite), which are generally coated with dextran, polyethylene glycol (PEG), or other polymers, and are used for clinical MRI [78 -82] . Based on their size, these NPs have been classified as magnetic IONPs (MION, μ m), superparamagnetic iron oxide (SPIO, hundreds of nm), ultrasmall paramagnetic iron oxide (USPIO, < 50 nm) and down. The SPIO CAs have been essentially used clinically for the diagnosis of liver diseases [83] , whereas the USPIO probes are generally used for lymph node imaging, angiography, and blood pool imaging [84 -89] . Besides their clinical use, the MRI CAs based on IONPs are actually developed for studying the biological processes. Significant contributions in this research area have illustrated the potential use of these particles for molecular and cellular imaging applications [78, 80, 82, 90 -94] .
As an example [95] , transferrin (Tf)-SPIONs were injected intravenously in a rat bearing two tumors with different levels of transferrin receptor (TfR) and MRI performed ( Figure 1 ). The decrease in T 2 relaxation time was much more pronounced for the tumor expressing high levels of the TfR compared to the tumor expressing low levels of the receptor showing that both in vitro and in vivo MRI can be significantly improved when IONPs are targeted toward cell surface receptors that are overexpressed in tumors. A better understanding of imaging biology could significantly influence the design, synthesis, and efficacy of MRI probes.
The efficiency of iron oxide probes as T 2 CA is sizedependent and increases with higher particle crystallinity [26, 79, 86, 96, 97] . However, these NPs, generally synthesized at low temperatures, have poor crystallinity associated with small size and lack of monodispersity, as also found for the other nanomaterials [98] .
Another challenge for this class of CAs is the development of efficient methods for their dispersion in the biological media and surface functionalization for biological targeting. Their encapsulation in a silica coating [99] may be a good option as it provides a colloidal stability in the biological solutions by avoiding interparticle interactions and agglomeration. Furthermore, it can act as an anchor for the binding of the biological vectors at the NPs ' surface. The thickness of the silica shell has also a strong influence on the physical properties of the NPs, especially in terms of CA efficacy for MRI. An ideal shell thickness was determined to be around 35 nm [100] .
The inherent negative contrast associated with IONPs has limited their use in low-signal regions of the body or in organs with intrinsically high magnetic susceptibilities, for example, the lungs. To solve this problem, specific methods based on either pulse sequences [101, 102] , design [103] , or size control [76] of NPs have been developed by researchers to generate a bright contrast from the IONPs.
Other T 2 -based NP CAs with improved magnetic and physicochemical properties have been developed such as paramagnetic dysprosium nanomaterials (NPs and nanorods) [104, 105] . Their negligible r 1 relaxivity enhances T 2 MR imaging because, in that case, the protons are nearly exclusively induced for T 2 MR imaging at a negligible r 1 
Other probes

PARACEST nanoparticles
NP CAs are also now used as paramagnetic chemical exchange saturation transfer (PARACEST) agents when they display bound water signals that can exchange protons with the bulk water. PARACEST MRI relies on these exchangeable protons that resonate at a chemical shift, which is clearly distinguishable from the bulk water signal due the paramagnetism of the particle.
Radio frequency prepulses when applied at an appropriate frequency saturate the exchangeable protons, which transfer into the bulk water pool and lead to a reduced equilibrium magnetization allowing the image contrast to be switched ' on ' and ' off ' by a simple change of the pulse sequence parameters. To enhance the inherent insensitivity of MRI to PARACEST agents and improve the limit of detection of these agents, nanoscale carriers have been developed such as liposomes, dendrimers, polymers, adenovirus particles, and perfluorocarbon NPs [79, 107 -109] . The unique MRI properties of such NP systems generate a large interest in potential medical applications.
Metal nanoparticles
Ferromagnetic cobalt particles coated with gold (Au) for biocompatibility with a unique shape that enables optical absorption over a broad range of frequencies were used for MRI and photoacoustic tomography (PAT) so as to detect picomolar concentrations of NPs. This dual-modality probe revealed very useful for the detection of trace amounts of NPs in the biological tissues in which MRI provides volume detection, whereas PAT performs edge detection [110] . Water-soluble cobalt oxide nanocrystals (CoO NCs) were obtained via a phase-transfer method with amphiphilic surfactants, such as anionic (sodium dodecyl sulfate (SDS)), neutral (Pluronic F127, PF127), and cationic (cetyltrimethyl ammonium bromide, CTAB) [111] . A field-dependence of the magnetization on the type of surfactants showed the crucial role of the latter. The longitudinal relaxivities ( r 1 ) and transverse relaxivities ( r 2 ) of the functionalized CoO NCs gave a r 2 
Quantum dots
Quantum dots (QDs) exhibit broad absorption spectra, large absorption cross-sections, narrow and tunable emission spectra, high-fluorescence quantum yields, and high photostability [115] . For all these reasons, they are extremely popular in fluorescence imaging application. Their optical properties enable bicolor [116] and even multicolor imaging, with different-colored QDs used in a single assay with only one excitation source [117] . This is illustrated in Figure 2 , which clearly shows one of the first demonstrations of an in vivo simultaneous imaging of five different lymphatic flows and their trafficking to distinct lymph nodes. The versatility and use of multiple QDs in a single assay to visualize several lymphatic drainages in a mouse give rise to a new powerful tool. The NIR-emitting QDs comprise II -VI, IV -VI, and III -V compounds, such as CdSe, CdTe, HgTe, PbS, PbSe, PbTe, InAs, InP, and GaAs, as well as alloys of these materials, and core@shell structures, which can allow the emission tuning further and alter the fluorescence lifetimes. Interesting probes are based on self-illuminating QDs, using fluorescence resonance energy transfer (FRET) from bioluminescent proteins conjugated to the QD [118, 119] . However, the potential toxicity due to heavy metal ions has to be taken into account and may be detrimental for their use in clinical bioimaging [120] and limit their use to in vitro and diagnostic assays. However, they have been used successfully in a sentinel lymph node mapping using intraoperative NIRF imaging [121] and more recently, in nonhuman A Figure 2 In vivo five-color lymphatic drainage imaging pointing at five distinct lymphatic drainages. (A) In vivo and intrasurgical spectral fluorescence imaging of a mouse injected with five carboxyl QDs (565, blue; 605, green; 655, yellow; 705, magenta; 800, red) intracutaneously into the middle digits of the bilateral upper extremities, the bilateral ears, and at the median chin, as shown in the right-hand side schema. Five primary draining lymph nodes were simultaneously visualized with different colors through the skin in the in vivo image and were more clearly seen in the image taken at the surgery. Reprinted, with permission from Ref. [117] . Copyright (2007) American Chemical Society.
primates [122] . The authors showed that rhesus macaques injected with phospholipid micelle encapsulated CdSe/CdS/ ZnS QDs did not exhibit evidence of toxicity. Blood and biochemical markers remained within normal ranges following treatment, and the histology of the major organs after 90 days showed no abnormalities. They deduced that acute toxicity of these QDs in vivo can be minimal even if chemical analysis revealed that most of the initial dose of cadmium still remained in the liver, spleen, and kidneys after 90 days, significant of slow breakdown and clearance of QDs.
Dye-doped nanoparticles
The NIR dye-doped silica NPs are becoming the popular choices of CA for several reasons: silica NPs are optically transparent, water dispersible, biologically inert, nontoxic in the amorphous form, with well-established conjugation strategies to modify the surface to proteins, peptides, and other ligands for cellular receptors using silane chemistry. The use of such a matrix, in which many NIR fluorophores can be encapsulated, reduces the potential toxicity of these fluorescent probes and shields the NIR emitter from the aqueous environment, where the dye usually suffers from low-fluorescence quantum yield, degradation, and unsatisfactory photostability. The NIR-emitting dyes such as polymethines (Cy5.5, Cy7), indocyanine green (ICG), Alexa Fluor 750, and IRDye78 have already been incorporated into silica NPs. The encapsulation of multiple dyes within a single silica NP generates much brighter and more stable probes than those loaded with a single one. The dye-doped silica NPs are usually synthesized by a sol-gel St ö ber process or in microemulsion by simply adding the dye (or a modified form of the dye) to the silicaforming solution [123] . In addition, the use of mesoporous silica NPs enables the loading of additional functions into the resulting pores, for example, the imaging probes of sentinel lymph nodes (SLNs) known as the first defense against primary tumor metastasis [124] , sensing [125] , or a therapeutic agent capable of photothermal ablation (PTA) or a controlled drug release [126] . The covalent chemical grafting of the lanthanide complexes on the metal oxide NPs was also recently performed, and the introduction of two different lanthanides gave bimodal CAs [64, 65, 127] .
Upconverting nanomaterials
The fluorescence imaging for small animals has received an increasing attention due to its ability to obtain anatomical and physiological details of living systems [128] . Most of the conventional fluorescence probes for bioimaging are based on single-photon excitation, emitting lowenergy fluorescence when excited by high-energy light. These single-photon probes exhibit some limitations such as (i) DNA damages with cell death due to long-term exposure to high-energy excitation; (ii) low SNR due to the significant auto-fluorescence of the biological tissues; and (iii) low penetration depth in the biological tissues.
As opposed to visible light excitation, near-infrared (NIR) light excitation for in vivo imaging provides several advantages, such as deep penetration, weak autofluorescence, minimal photobleaching and low phototoxicity. In particular, two-photon-excited fluorescence imaging based on the anti-Stokes luminescence process revealed a useful strategy for the imaging of the living brain to reduce autofluorescence [129] .
The nanocrystals with both excitation and photoluminescence (PL) in the biological optical transparency window combined with high quantum efficiency, spectral sharpness, and photostability, makes them extremely promising as optical bioimaging probes. Rare-earth upconversion nanophosphors (UCNPs) belong to this new generation of luminescent probes for small-animal imaging. When excited by continuous-wave NIR light, they exhibit a unique narrow photoluminescence with higher energy. This upconversion luminescence (UCL) makes UCNPs promising as bioimaging probes with attractive features, such as suppression of the autofluorescence from biological samples and a large penetration depth. As a result, UCNPs have emerged as novel imaging agents for small animals. Rules suitable to develop new optical labels for in vivo NIR optical imaging procedures were reported [130] . Later on, in their critical review [131] , Li et al. have recently reviewed the recent developments in the preparation, surface modification, and bioconjugation chemistry of these UCNPs and their applications in bioimaging and multimodality imaging of small animals.
Among others, upconverting NPs, developed as agents for in vivo fluorescence imaging, are doped with rareearth ion derivatives [132] . They absorb NIR light (usually around 980 nm) and emit upconverted light at a higher energy, usually in the green or far-red/NIR, with long fluorescence lifetime ( μ s to ms) [133, 134] . For example, polyethyleneimine-coated NaYF 4 :Yb,Er and NaYF 4 :Yb,Tm NPs when exposed to a 980-nm NIR laser could be used as upconverting NPs and evidence of the first demonstration of the use of upconversion fluorophores for cellular and tissue imaging via the imaging of visible fluorescence through the mouse thigh muscle down to 10 mm depth [135] . The Er-doped or Yb/Er-doped ceramic phosphors were synthesized and partly modified with PEG to give dispersion and controlled interaction with the biological objects. The NIRF of nematodes, mouse tissue, and M1 cells was observed by detecting 1.5-μ m emission from the Er doped in the ceramic phosphor [136] . In the same way, a new generation of 3 + lanthanide NPs of NaYF 4 proved to be the multimodality nanoprobes not only for UCL but also for PET and MR imaging [137] . The presence of Yb 3 + and Er 3 + codoped in the NaYF 4 NPs gave rise to the intense UCL emission in the visible and relaxivity for MRI. Successful labeling of the lanthanide NPs with 18 F gave a particle suitable for PET imaging. In vivo PET/MR entire-body imaging of small animals and ex vivo UCL imaging experiments on the biodistribution of 18 F-labeled lanthanide NPs in the small animals indicated the effectiveness of such NPs as a multimodality nanoprobe as discussed later on. The functionalized Y 2 O 3 -based upconverting NPs also form a promising platform for the in vivo optical-based diagnostic imaging with an excellent photostability in the NIR as well as a low toxicity [138] . The Yb-and Er-doped version of the yttrium oxide NPs (Y 2 O 3 :YbEr-NPs) exhibit, besides a visible UCL, a strong NIR emission under NIR excitation (NIR-NIR emission): the particles show bright green (550 nm) and red (660 nm) upconversion (UC) as well as NIR fluorescence (1550 nm) under 980 nm excitation [139, 140] . These NPs with NIR fluorescence at energies lower than their excitation wavelength could provide more advantages for bioimaging applications.
When judiciously coated, some YF 3 :Yb 3 + /Er 3 + NPs lead to upconversion luminescence in the NIR (831 nm) rather than in the visible, which enables a greater penetration of the light [141] . Other examples include core@shell NdF 3 @ SiO 2 ( α -NaYbF 4 :Tm 3 + )@CaF 2 , NaGdF 4 :Nd 3 + @NaGdF 4 NPs, which also have excitation and emission in the NIR range and efficient deep-tissue imaging of small animals [133, 142] . All of these materials were modified as to become dispersible in aqueous solutions and conjugated to the relevant biomolecules for targeting purposes.
Carbon nanomaterials
Carbon-based nanomaterials are also potential NIR CAs for in vivo imaging. The NIR photoluminescence intrinsic to the semiconducting single-walled carbon nanotubes (SWNTs) is ideal for the biological imaging through the low autofluorescence and deep-tissue penetration in the NIR region beyond 1 μ m [143] . Their NIR fluorescence also offers a powerful approach for sensor development and in vivo or real-time imaging of biological systems [144] . They present an emission in the second IR window (1000 -1350 nm), which would enable even deeper light penetration. The toxicity of SWNTs is still a controversy; their surface chemistry, therapeutics applications, and toxicology as well as their use in biomedical imaging were reviewed [145] . A recent strategy to functionalize CNTs with bioactive glycoproteins, glycolipids, and glycodendrimers led to a series of biocompatible and water-soluble CNTs, which exhibit highly selective interactions with proteins and living cells. Their biomedical applications in cell sensing, gene delivery, bioimaging, biosensors, and bone tissue engineering were analyzed in a review paper [146] . Bioanalytical applications and bioimaging of carbon dots (CDs) have been reviewed [147] . They exhibit the advantages of being excited by single-photon (ultraviolet or near-ultraviolet) as well as multiphoton (red or NIR) excitation, and their luminescence properties, are essentially due to surface defects. The CDs were found to have emission in the visible region when they are passivated by polymer chains [148] , doped with inorganic salts or photosensitizer [59, 149 -152] . These materials are being investigated for optical imaging agents using both one-and twophoton excitation [153] . Despite the fact that small animal or thin tissue imaging has been largely illustrated, clinical applications have not been yet proven.
The colloidal diamond NPs (i.e., nanodiamonds) are yet another nanomaterials being investigated as potential in vivo fluorescent probes for biological and medical imaging. They have been shown to be biocompatible, not cytotoxic, and to have a highly reactive surface that is easily functionalized with biological entities [154] . These nanodiamonds emit single-photon luminescence when stimulated by laser light owing to a number of different point defects based on the different types of vacancies. The comprehensive reviews on nanodiamonds [155] , their use as biolabels [156] and in nanomedecine [157] have been published.
Similar to these luminescent carbon dots (C-dots), graphene QDs or graphene quantum discs (GQDs) have generated an enormous excitement because of their superiority in chemical inertness, biocompatibility, and low toxicity. Besides, GQDs, consisting of a single atomic layer of nano-sized graphite, have the excellent performances of graphene, such as high surface area, large diameter, and better surface grafting using π -π conjugation and surface groups [158, 159] .
Other probes and NIRF techniques
Luminescent porous silicon NPs (LPSiNPs) emitting at ∼ 800 nm are also attractive candidates, excitable by NIR or two-photon excitation ( Figure 3 ), and as opposed to most optically active nanomaterials (carbon nanotubes, gold NPs and QDs), they can self-destruct in a mouse model into kidney cleared components in a relatively short period of time with no evidence of toxicity [160] .
Positron emission tomography (PET)
PET is a nuclear medicine imaging technique that produces a three-dimensional (3D) image or picture of the functional processes in the body. The system detects pairs of gamma rays emitted indirectly by the radionuclide by which they are introduced into the body on a biologically active molecule. It relies on the detection of a positron emitted by radioisotopes (tracer); 3D images of the tracer concentration within the body are then constructed by computer analysis. Approved and used on a daily basis as a clinical molecular imaging technique with a resolution of 1 -2 mm [54] , it presents, however, a relatively low spatial resolution, which needs be improved. However, PET exhibits the highest sensitivity of all imaging modalities, which enables the quantification of the local concentration of radionuclide tracer, with only a few trace isotopes [55, 161] . Furthermore, PET penetration depth is unlimited, so the probe can always be imaged, irrespective of the target location. Especially important in cancer imaging and research, PET is capable of detecting molecular changes that are occurring in the body before the macroscopic disease is observed [37, 89, 162] and of monitoring disease progression after treatment (i.e., tumor response to therapy) [163] .
Over the past decades, positron emitter labeled NPs have been widely used and substantially improved in a wide range of diagnostic biomedical research. One of the main challenges in this field is now to develop diseasespecific nanoprobes with facile and robust radiolabeling strategies. These nanoprobes should also provide (i) imaging stability, (ii) enhanced sensitivity for disease early stage detection, (iii) optimized in vivo pharmacokinetics for reduced nonspecific organ uptake, and (iv) improved targeting for high efficacy. A variety of NPs have been engineered and explored for diagnostic and therapeutic potential in various diseases and lately reviewed [164] . They are essentially labeled with PET isotopes for cardiovascular, pulmonary, and tumor imaging, as well as for pharmacokinetic evaluation [161] .
Radionuclide labeled nanoparticles
Common isotopes that can be chelated onto or incorporated within NPs (in an analogous way to the gadolinium ions used for MRI) include 18 F, 11 C, 15 O, 13 N, 64 Cu, 124 I, 68 Ga, 82 Rb, and 86 Y. PET imaging using 18 F, which is the most widespread radionuclide probe used in this field, has become an established clinical tool for whole-body imaging. In light, its short half-life, its quick conjugation into the probe with a high reaction yield, is necessary to improve its efficiency and to reduce cost. A general synthesis strategy for such 18 ) and fluoride ions [165] . The 18 F-labeled rare-earth NPs were further evaluated by PET imaging, for their in vivo distribution and their application in lymph monitoring. There are, however, other types of probes and the main NP-based PET ones, and their labeling radionuclide are reported in Table 2 .
F-labeled rare-earth NPs was developed through a facile inorganic reaction between
The pharmacokinetic and in vivo cancer targeting issues of 64 
Cu
2 + ions functionalized gold nanocages (NCs) ( Most of the time, the PET tracers are incorporated with another modality in the NPs, most notably CT [199 -202] . Figure 5 illustrates the use of 18 F-doped cross-linked iron oxide modified trimodal NPs (18F-CLIO) to image the liver and blood pool of a mouse. The in vivo dynamic PET imaging showed very high SNRs for the injected They showed particularly avid and stable binding of 18 F-fluoride in various biological media. The in vivo behavior of the 18 F-labeled hydroxyapatite particles determined by PET-CT imaging in mice showed that hydroxyapatite was stable in circulation, but its accumulation in the liver via reticuloendothelial clearance was followed by gradual degradation and release of 18 F-fluoride (over a period of 4 h), which then accumulated in the bone.
Coupling with other contrast agents
Among the other modalities that have been combined with PET, it should be mentioned that ultrasmall cancerselective silica particles grafted with iodine and dyedoped polymers were recently approved by the FDA for in-human clinical trials [203] , NIRF agents within the silica NPs [204] or QDs [168, 205, 206] , and MRI [199] agents in conjunction with iron oxide nanomaterials [35, 171] . A bifunctional chelator [dithiocarbamate bisphosphonate (dtcbp)], containing a dithiocarbamate group for binding the PET isotope 64 Cu and a bisphosphonate group for strong binding to Fe 3 O 4 , was elaborated . Dtcbp efficiently binds 64 Cu to form the [ 64 Cu(dtcbp) 2 ] complex, which is then grafted on the IONPs leading to a PET-MR dual modality imaging system which in vivo accumulates in draining the lymph nodes ( Figure 6 ) [173] .
However, the ratio between the PET tracer and the MRI CA must be carefully controlled because PET is extremely sensitive, whereas MRI is not.
SPECT is a similar technique that can also detect nanomoles of tracers. SPECT is based on the detection of the lower-energy γ -emitting radioisotopes such as 99m Tc, 111 In, 123 I, and 131 I [14, 207 -209] . Compared to PET, SPECT has the advantage to be more sensitive and versatile; it is cheaper and more widely available as it does not rely on a local cyclotron for the production of isotopes even if it is an order of magnitude less sensitive than PET.
The covalent functionalization of the radionuclidefilled SWNTs were used as radio probes [210] . The intravenous (IV) administration of these 125 I-loaded SWNTs was tracked in vivo using SPECT. Specific tissue accumulation (here lung) coupled with a high in vivo stability prevented the leakage of radionuclide to the high-affinity organs (thyroid/stomach) or excretion and resulted in ultrasensitive imaging and delivery of unprecedented radio-dose density. The nano-encapsulation of iodide within the SWNTs enabled its biodistribution to be completely redirected from the tissue with innate affinity (thyroid) to the lung ( Figure 7 ). 18 F-CLIO. The NP had a vascular half-life of 5.8 h in mice and was internalized into the macrophages of the liver, spleen, and the phagocytic cells of the other lymphatic organs. The NP is additionally biodegradable and breaks down into elemental components within months. PET/ CT allows concentrations at 2 -4 orders of magnitude lower than those required for MR imaging, which likely makes PET imaging an important platform for clinical molecular according to the authors.
Biocompatible inorganic NPs such as hydroxyapatite NPs also revealed as useful PET/CT probes [178] .
X-ray imaging and computed tomography (CT)
X-ray CT is one of the most powerful noninvasive diagnostic imaging techniques in modern medicine. It has been a clinical tool for more than half a century, and the first widespread clinical use of NPs as X-ray CAs in humans were 3-to 10-nm thorium dioxide NPs [12, 211] . However, due to the long-term radiation effects and significant carcinogenicity of the 232 Th, its clinical application was rapidly given up.
Iodinated molecules were then used as CT CAs in the clinics. They, however, have relatively short in vivo circulation times, which significantly restrict the applications of this technique in target-specific imaging and angiography. The use of large doses of these agents, which may induce serious adverse effects as well as a hypersensitivity to iodine in some patients, led researchers to address these issues. Over the past decade, advances in nanoscience brought some solutions; thanks to the unique properties of nanomaterials, such as their prolonged circulating halflife, passive accumulation at the tumor sites, facile surface modification, and integration of multiple functions into 
Iodinated nanoparticles
The widespread clinical use of the iodinated compounds has encouraged the development of iodinated nanomaterials. Research essentially focuses [213, 214] on the incorporation of the iodinated organic compounds into NPs, with designs ranging from emulsions [215 -218] , liposomes [214, 219 -223] , and lipoproteins [224, 225] to insoluble nanoobjects [214, 226 -228] , and polymeric NPs [215, 229 -233] ; many of them have been successfully applied in vivo [28, 56] . The purpose of these nanomaterials is to locally increase the iodine concentrations, resulting in a higher local contrast compared with the conventional water-soluble CT CAs. A key feature of many of these NPs is their pharmacokinetics, which are often markedly different from those of small iodinated molecules in clinical use. They have increased the circulation time with the subsequent implications for targeting because longer circulation times increase the chance of interaction and binding of the CA to a target.
Some multimodal NPs were doped with an iodinated compound and used to enhance X-ray contrast [216, 224, 234, 235] as discussed later on in the review. Iodine has a lower atomic number than gold and bismuth; it, however, exhibits higher elemental mass attenuation coefficient and incident X-ray energies so that, when compared to gold NPs under conditions used for coronary angiography, iodinated CAs had an equivalent performance [236] . When a CA was developed by combining the two radiodense elements iodine and gold within a single PAMAM dendrimer, it was demonstrated that the incorporation of both Au NPs and iodine-containing small molecules resulted in a significant cooperative enhancing effect in X-ray attenuation [237] .
Gold nanoparticles
In addition to the clinically used iodine, the element gold has received much attention due to its higher atomic number than iodine, and thus, a larger contribution of the photoelectron effect to X-ray attenuation, generating a substantial interest in gold NP-based CAs for the in vivo X-ray CT. Gold nanoobjects contain a large number of the contrast element (Au) as opposed to the iodinebased NPs in which iodinated molecules are often only covalently grafted onto the NP surface, thereby, lowering the concentration of the agent. Various gold [10, 61, 238 -240] , gold@dielectric hybrids [10, 241 -246] , and multimodal materials [96, 246 -248] have been fabricated and their in vivo functionality as X-ray CT CAs for cancer, specific tissues, and blood-pool imaging. The gold nanomaterials are currently being explored in multiple clinical trials, and they constitute a promising next-generation candidate for the X-ray contrast materials, radiotherapy [249 -251] , and cancer therapy [252] .
Other contrast materials
Other CT molecular imaging agents have also been studied besides iodinated and gold-based ones. These NPs consist of bismuth sulfide and composite ceramics containing iron oxide and lanthanide materials. Bismuth sulfide NPs have recently been shown to have a superior performance to iodine on a molar basis [253 -255] . Even if bismuth displays similar mass attenuation coefficients to that of gold and a higher K-edge transition, its toxicity may prevent bismuth-based nanomaterials ' clinical use as CT agents. Other types of CT CAs, are those based on iron oxide [256] and have recently been reviewed [94, 257, 258] . A facile approach for the fabrication of Fe 3 O 4 @ Au NPs as a dual-mode CA for both MRI and CT imaging applications has been performed via the combination of a layer by layer (LbL) self-assembly process and dendrimer chemistry [259] . The use of Fe 3 O 4 @Au NPs as a CA for dualmode MR/CT imaging has been demonstrated not only for in vitro imaging of cancer cells but also for in vivo liver imaging via MR and subcutaneous tissue imaging via CT.
The high atomic weight and large number of unpaired electron makes gadolinium an excellent contrasting agent both for MRI and CT imaging [12, 260 -262] . Therefore, most of the time, NPs are at least dual probe: CT/MRI or CT/NIRF [261, 263, 264] . As an example, Gd 3 + complexmodified NaLuF 4 -based upconversion nanophosphors were successfully applied for UCL, MR, and CT multimodal imaging, by integrating NIR-to-NIR UCL, X-ray attenuation, and paramagnetic function in one single NP. The property of NIR-to-NIR UCL enhances the high SNR of in vivo imaging of small animals. Moreover, Gd 3 + grafting on the surface of NPs generates a high r 1 relaxivity for the core-shell NPs, which become suitable for T 1 MR imaging. In addition, this NP with the core of Yb , Tm 3 + @ SiO 2 -GdDTPA, provides a facile design strategy to fabricate multimodality imaging agents [261] .
Yb-based NPs (NaYbF4:Er), which already revealed to be efficient upconversion nanophosphors (UCNPs), have also recently been identified as CT contrasts agents [265] . When encapsulated in a polymer (PEG) shell, they showed low cytotoxicity and long circulation time in vivo and a much higher efficacy compared to the clinical iodinate agents commonly used. This improvement was attributed to the K-edge energy of Yb that locates within the higherenergy region of the X-ray spectrum. Furthermore, a gadolinium doping in these NPs endowed them with enhanced fluorescence as well as NMR imaging capabilities provided that clearance issues are solved.
By virtue of its high atomic number and this wellpositioned K-edge, Yb provides excellent spectral CT contrast both in vitro and in vivo [266] . To partly solve bioelimination and preliminary biodistribution issues, Yb nanocolloids were used as spectral CT CAs. The synthetic approach involved an organically soluble organometallic Yb(III)-2,4-pentadionate complex to produce polysorbate encapsulated nanocolloids of Yb incorporating a high density of Yb ( > 5 × 10 5 per NP) into a stable metal particle. Such high payloads of the Yb in the form of hydrophobic small molecule metal complexes could be obtained and stably concentrated into lipid-encapsulated nanocolloids and provide novel molecular imaging for use for spectral " multicolor " CT.
Ultrasound (US)
US is also a well-established clinical imaging modality. In particular, it is routinely used to characterize lesions in the liver, urogenital tract, head, neck, and soft tissues. Its main advantages are (i) the ability to extract molecular information, (ii) portability, (iii) cost-effectiveness, (iv) absence of ionizing irradiation, (v) high spatial and temporal resolution (real-time examination), and (vi) global availability. It is based on the pulse-echo principle, with emitted and received wave ' s frequencies higher than 20 kHz. US clinical application involves sound waves in the range of 2 -3 MHz for pediatric imaging and 5 -12 MHz for adult imaging, providing spatial resolution in the range 0.2 to 1 mm [28] .
Contrast in US is provided by the variable ability of sound to propagate through media, resulting in reflection and refraction of the sound waves. Reflection and refraction not only depend on the sound itself but also on the nature of the medium and of its density. Therefore, several microbubble-based CAs have been developed and are applied clinically to enhance the echogenicity of vasculature and organ-specific regions [267 -272] . These microbubbles are composed of surfactant, protein, and/ or polymer shells containing gas cores; for example, air, perfluorocarbons, or nitrogen should have an optimum size of 2 -3 μ m for common imaging practice [273] . CAs for USI echogenic liposomes [274 -276] , perfluorocarbon droplets [277] , and other materials such as gold particles have a density and compressibility substantially different from that of blood and tissue.
The use of nanobubbles [29, 278 -286] as US CAs is in constant progress. Even if they are named as nanobubbles, they are typically in the range 150 to 1000 nm in diameter. They are generally composed of a perfluorocarbon gas encapsulated by a surfactant, protein, and/or polymer shell. The clinical significance of US, as well as the labeling advantages of the nanomaterials, prompted a continued interest in developing smaller US CAs [287 -289] . Despite this increasing interest, one should mention that due to lower scattering cross sections and, often, low mechanical properties of the shell, the performance of these nanomaterials is often inferior to that of microbubbles.
As for other imaging techniques, there is a general trend to combine both imaging and therapy. A solution was proposed that consisted of a medical imaging CA combining both NPs and microbubbles for imaging and therapy applications in a single agent, resulting in a more accurate diagnosis and local treatment of diseased tissue. Various silica-coated NPs (e.g., CdSe/ZnS QDs, Au NRs, Fe 3 O 4 , and Gd-loaded silica NPs) were incorporated into highly monodisperse, microfluidic-generated compressible protein-lipid-coated, perfluorobutane microbubbles (with size control down to 3 μ m) [290] . When diluted in saline, the NP-incorporated microbubbles are detectable using low-pressure US. They can be produced at highthroughput, sufficient for in vivo usage (106 MB/s).
The polymeric micelles and perfluorocarbon nano/ microbubble systems that encapsulated a drug, which can be released locally within tumor cells, were also obtained; US was then used to determine the efficacy of this drug therapy [278, 279] . Designed redox polymer NPs were shown to reduce intracerebral hemorrhage induced by 1-MHz focused US sonication coupled with microbubble treatment. Sonication coupled with redox polymer NP-loaded microbubbles produced intracerebral hemorrhage, but the incorporated redox polymer NPs had a significant neuroprotection on the intra-cerebral hemorrhage-induced brain [291] .
The microbubbles can potentially be used as carriers for the nanoscale US CAs and the incorporation of multimodal probes with potential therapeutic applications: sonodynamic therapy, US-induced apoptosis, sonoporation/sonotransfection, US-induced drug/gas delivery, and focused US-induced thermal ablation [32, 33, 280, 292 -299] . Very recently, the mesoporous silica nanocapsules were also used as US CAs and can be can be potentially used as the inorganic theranostic platform for contrastintensified USI, US-induced cytoclasis and drug release, and US-guided efficient HIFU tumor ablation therapy [300] .
Photoacoustic imaging (PAI)
PAI [301] , also known as laser optoacoustic imaging, is an emerging noninvasive, nonionizing, imaging modality that combines the high sensitivity of optical methods with the excellent resolution of acoustic methods [302, 303] . When illuminated by a short-pulsed laser, the biological sample absorbs the given light, and this excitation is followed by a transient increase in temperature ( ∼ 10 mK) and subsequent thermoelastic expansion of the absorbent. This generates an ultrasonic acoustic signal, which is detected by wideband transducers surrounding the object and is used to determine its geometry. Electromagnetic energy in the optical from visible to near-IR and radiofrequency regions is often utilized for PA excitation in the soft tissues. This is not only because electromagnetic waves in these regions are nonionizing and safe for human use but also because they provide both high contrast and adequate penetration depths in biological tissues. PAI is generally performed using two main techniques, photoacoustic microscopy (PAM) and photoacoustic CT (PAT) [301, 303, 304] . PAM uses a coupled, focused ultrasonic detector-confocal optical illumination system [302] to generate multidimensional tomographic images without any reconstruction algorithms, whereas the detectors in PAT scan the laser-illuminated object in a circular path and use inverse algorithms to construct 3D images [301, 305 -307] .
While in vivo imaging with optical techniques suffers from hemoglobin absorption and tissue scatter, which limit overall light penetration depth, PAI can overcome this primary drawback, thanks to the lower ultrasonic scattering coefficients (by 2 -3 orders of magnitude) of the absorbents compared with their optical equivalents leading to the ∼ 5-cm depth analysis with a resolution of < 1 mm [308, 309] . The depth issue can even be completely eliminated when microwaves or radiowaves (referred to as thermoacoustic tomography (TAT)) are used as illumination sources [310 -313] .
Gold-based nanomaterials
Gold-based nanomaterials are the most significant class of materials explored for PAT applications. Some of those commonly used for PAT include spherical gold NPs [304, 314 -320] , nanorods [321 -327] , nanostars [328] , nanocages [305, 329 -334] , hollow nanoshells [335] , and composite materials with gold nanoshells: SiO 2 @Au, [306, 336, 337] Fe 3 O 4 @Au, [314] cobalt@gold NPs, [110] gold-speckled silica [316, 320] , and gold nanobeacons [338, 339] . The reasons for such an attention to gold nanosystems are many fold: they have tunable size-and shape-dependent plasmonic properties [340, 341] , which allow them to absorb and scatter light from the visible to NIR region and make them suitable for image-guided therapy [325, 342 -344] and PTA of tumors [345 -347] . A comparison of gold plasmonic nanostructures (surface plasmon resonance (SPR) tuned to 800 nm) revealed that gold nanorods and nanocages have much larger absorption and scattering cross sections than gold nanoshells [348] .
The gold nanorods have similarly been used as NIR photoacoustic CAs with high sensitivity [349] . Manipulation of the aspect ratio enables the tuning of the SPR of the resulting nanorods, which has led to multiplexing applications [321, 324, 326, 327, 344] . The gold nanorods are also effective as tracers for noninvasive in vivo spectroscopic photoacoustic SLN mapping in a rat model [350] .
When they are silica-coated, the gold nanorods show increased photoacoustic [344] and photothermal stability and retain their superior optical properties under much higher fluences [323, 325] when compared to PEG-coated gold nanorods, which implies better imaging capabilities and make silica-coated gold nanorods a promising imaging and therapeutic nano-agent for PAI and image-guided photothermal therapy. A recent paper reported the use of silica-coated gold nanorods in PAI for the quantitation of mesenchymal stem cells (MSCs) in rodent muscle tissue. The silica coating increased the uptake of gold into the cell more than fivefold, without any sign of proliferation changes in cells suggesting that the therapeutic benefit of the MSCs will be retained despite the presence of CA [351] .
The gold-based compounds have a low toxicity [13, 345, 352 -355] , which makes them good candidates for clinical and medicinal applications [252, 354, 356] . Gold nanoobjects are also used as multimodal systems, which will be addressed later on.
Carbon nanomaterials
The carbon nanomaterials have been considered as potential biomedical materials for pharmaceutical, biomedical [357, 358] , and bioimaging applications [359 -362] , including PAI [363 -372] and thermoacoustic imaging [373] . The characteristic optical properties of SWNTs, particularly those with optical properties in the NIR region [374] , play an important role in PAI [375] .
As an example, SWNTs conjugated with cyclic ArgGly-Asp (RGD) peptides can be used as a CA for PAI of tumors. IV administration of these targeted SWNT ( ∼ 2 nm in dia meter and 50 -300 nm in length) nanotubes to mice bearing tumors showed eight times greater photoacoustic signal in the tumor than mice injected with the nontargeted nanotubes [376] . The antibody-conjugated SWNTs targeted to integrin α v β 3-positive U87 human glioblastoma tumors in mice generated a high photoacoustic contrast in vivo [377] . As an alternative and noninvasive approach to the detection of the SLN, the SWNTs have been shown to result in a significant signal enhancement for the detection by PAI [378] . To overcome the limitation of their relatively low absorption coefficients, the nanotubes are modified, enhancing their NIR absorption and, thus, photoacoustic contrast. In one report, the nanotubes were plated with a thin layer (4 -8 nm) of gold; the use of these golden carbon nanotubes (GNTs) resulted in a 100-fold increase in photoacoustic signal enhancement [379, 380] . The photoacoustic signals of GNTs compared to other NIR CAs exhibited higher PA signals and correspondingly lower bubble-formation thresholds than those of pristine carbon nanotubes and gold NPs and comparable properties to those of gold nanorods and nanoshells [380 -382] . The antibody-conjugated GNTs were used to target lymphatic vessels in vivo by PAI. In another modification of SWNTs, ICG dye molecules were attached to the surface of the nanotubes by π -π stacking interactions and showed a 20-fold higher absorbance than bare SWNTs as illustrated in Figure 8 [371] . The synergy between the NIR absorption property of the dye and SWNT led to SWNT-ICG nanomaterials, which provide an ∼ 300 × improvement in photoacoustic sensitivity compared with the unmodified SWNTs in vivo . In a recent work [383] , the novel probe, based on the reduced graphene oxide (RGO)-IONP nanocomposite, was noncovalently functionalized with a biocompatible polymer, PEG, for the applications in multimodal imaging-guided photothermal therapy of cancer based on PAT. Using this theranostic nanoprobe, in vivo triple modal fluorescence, photoacoustic, and MRI are carried out, uncovering high passive tumor targeting, which is further used for the effective PTA of tumors in mice.
Other types of nanoparticles
The encapsulation of dyes within the protective NPs would certainly provide additional advantages in improving image contrast [384] due to signal amplification, reduced chemical as well as photodegradation, and additional ability to target specific biologically relevant sites [385 -387] . In the selection of a dye, the relevant absorption profile is a key point, but others can also be crucial, such as fluorescence imaging or therapeutic function such as photodynamic therapy (PDT) [126, 388 -391] . ICG is the most commonly used for PAI in the molecular and nanoparticulate formulations because it is the only FDA-approved dye for human applications. Its absorption peak at ∼ 780 nm lies within the biological NIR window and enables deep-tissue imaging only if encapsulated in the NP matrices: organically modified silica (ORMOSIL), poly(lactic-co-glycolic acid) (PLGA), and calcium phosphate) due to its short plasma half-life (4 min). As such, it has shown an improved stability and longer blood circulation time [392] .
SPIO NPs (SPIONs), which have been widely used as the FDA-approved CAs for MRI and are known to have an excellent safety profile [80, 81] , were also analyzed for photoacoustic applications. With such NPs, PAI, which enhances the imaging contrast by visualizing the optical absorption of either the tissue or injected CAs, could be coupled with magnetomotive US (MMUS) imaging, which enhances the sensitivity and specificity of US based on the detection of the magnetic NPs perturbed by an external magnetic field. This integrated magneto-photo-acoustic (MPA) imaging helped in identifying the morphological properties, molecular information, and complementary functional information of tissues [393] . The same MPA imaging used to noninvasively detect the delivery and endocytosis of NPs could differentiate the endocytosed NPs from the extracellular NPs in the background tissue and is promising for the in vivo studies of cellular functionality [394] . Another study demonstrated the potential of core-shell IONPs with silica coating as the PA CAs under 1064-nm laser excitation; the increased thermoelastic response of the silica-coated SPION compared to the bare ones was assumed to be due to the enhanced optothermal properties of the core-shell structure [395] . Besides inorganic NPs, there are also studies on the use of polymeric nanoobjects for PAI [386, 387, 396, 397] .
Terahertz molecular imaging (THMI)
Terahertz (THz, 1 THz = 10 12 Hz) molecular imaging (THMI) is a new analytic technique that detects changes in the surface plasmons (SPs) emerging from NPs following the irradiation with an optical laser beam. Owing to the high absorption of THz radiation in water, which is the main component of biological tissues, a high contrast between the skin, muscle, fat, veins, nerves, etc., can be obtained. In particular, this high sensitivity of THz to the concentration of water provides a high contrast between tumor (high water content) and normal tissues. Thus, characterizing the refractive index and absorption of various tissues is the key to the use of THz in the Life Sciences both for spectroscopy and imaging and in the design of biochips.
THz technology has then been advancing rapidly because of these tremendous potential applications. Among them, THz cancer diagnosis is drawing much attention as THz waves can detect the variation of cells caused by cancer, thereby, rendering a new modality of medical imaging. Conventional THz imaging for cancer diagnosis assesses the difference in water content or structural changes between tumor and normal tissues. However, the use of THMI nanoprobes improved the sensitivity of the conventional THz imaging by providing a target-specific THz image and by enabling the assessment of molecular and cellular activities via the analysis of THz waveforms [398, 399] . The sensitivity of THz electromagnetic (EM) waves to water molecules allows the utilization of the THz technique in diagnosing cancers because in cancerous tumors, diseased tissues contain more interstitial water than healthy tissues. This higher water content, combined with the structural changes such as increased cell and protein density, leads to a larger THz absorption and refractive index for tissues with tumors.
Gold nanoobjects
The THz spectroscopy is advantageous in analytical chemistry because it can detect and identify intermolecular interactions in chemical compounds, such as hydrogen bonds and hydrations, and molecular networks. The recent advances in THz components, such as ultrashort pulsed lasers and photoconductive antennas, have improved the sensitivity of THz time-domain (TDS) spectroscopy and have made the THz chemical imaging much efficient. The THz chemical imaging can reveal hydrogen bond distributions and will be a very powerful tool in biology, pharmacology, and life sciences. The problem with THz cancer diagnosis is the difficulty in identifying the tumor in the tissues at an early stage. Antibody-conjugated CAs for THz EM waves, similar to the technique adopted in MRI, may solve the problem. This was first performed using the so-called NP-CA-enabled terahertz imaging (CATHI) technique by targeting metal NPs such as the gold nanorods (GNRs) to the cancer cells in tumors The THz reflection amplitude from the cancer cells with the GNRs increased by 20 % upon IR laser irradiation compared to the cancer cells without GNRs. In a differential mode, the difference between the two cases was more evident because the THz signal from the cancer cells with GNRs was 30 times higher than that from the cancer cells without GNRs [398] .
Cancer diagnosis by the THMI technique was also demonstrated by in vivo imaging A431 cancerous tumors in mice. The change in the THz response is due to the activation of the surface plasmon resonance on the surface of NP probes when illuminated with NIR beams. The development of a differential measurement technique in which the NIR beam is directly modulated instead of numerical subtraction of two images led to high SNR eliminating the background noise and generating a high sensitivity capable of identifying the miniscule differences at a cellular level [399] .
Metal oxide-based nanoparticles
Very recently, the commercially available suspension of the SPIO-dextran composites (Feridex) was also used as not only a MRI probe but also as a THMI one. They were transfected into SKOV3 cancer cells, at various concentrations, and both the magnetic and optical properties of the particles were examined by MR and THz reflection imaging. Mice were inoculated with Feridex-labeled SKOV3 cells, and in vivo MR and THz images were taken 1, 3, 7, and 14 days after inoculation. The THz images and T2*-weighted MR images showed similar patterns; the signal intensities of both image sets increased with Feridex concentration and decreased over time [93] .
Another MRI CA based on gadolinium oxide (Gd 2 O 3 ) NPs (GONPs) is receiving attention as a potential multifunctional CAs also active in THMI [400] . The optical constants of GONPs were found to be concentrationdependent by THz-time domain spectroscopy (TDS). Even a few μ m of GONPs could be detected due to their power absorption capacity, which is almost 3 orders of magnitude larger than that of water. Therefore, GONPs can significantly improve the contrast in THz images. Their encapsulation with biocompatible materials would probably prevent the aggregation problem of the GONPs.
As opposed to MRI technology, which has a difficulty to acquire images from a surface that is not surrounded by water such as the human skin or digestive organs, the THz medical imaging technology, however, has uniqueness on the surface measurement of the biological samples such as the epithelial cancers. Therefore, THz imaging, along with NP CAs, will probably be one of the strongest imaging technique for a certain diagnosis.
Ion beam analysis techniques
Besides QDs and gold NPs, many other inorganic NPs suffer from a lack of fluorescence in the optical regime and cannot be followed by light microscopy; therefore, there was a need for the development of X-ray fluorescence mapping, which is the main way to detect, track, and quantify NPs in vitro in the biological specimens.
The IBA techniques have been widely used for the determination of chemical element composition of the diverse types of specimens. The PIXE has proven to be a reliable and a highly sensitive technique for the detection and quantification of the chemical elements in living organism. The direct analysis of the biological samples is particularly convenient when IBA is performed with highresolution microbeam, also called nuclear microprobe. The use of high-resolution microbeam offers the opportunity to reveal the in vitro chemical imaging of the whole cell compartments (nucleus, cytoplasm) and to perform trace element quantification at the single cell level. The PIXE could also be performed on multicellular organisms deciphering the whole elemental composition of defined anatomic structures of interest to address the particular questions of bioaccumulation and biopersistence of endogenous/exogenous chemical elements, such as metal oxide NPs. In addition, because in vitro cell culture or microorganisms prepared for PIXE do not require sectioning, they can be investigated close to their natural state using cryogenic preparation methods.
The PIXE provides multielemental capability, which allows the simultaneous comparison of the distribution of several elements inside the same specimen [401 -410] .
TiO 2 is one of these nanomaterials that were largely examined by PIXE, the main reason being due to its extensive use in cosmetics and sunscreens. The analyses performed on the penetration depth and on the pathways of the TiO 2 particles into the skin showed a penetration of TiO 2 particles through the stratum corneum into the underlying stratum granulosum via the intercellular space. The TiO 2 particle concentration in the stratum spinosum was below the minimum detection limit of about 1 particle/ μ m 2 [411] . The state of aggregation of the TiO 2 NPs revealed to be crucial with regard to lung toxicity [412] . The biodistributions of Pt and TiO 2 micro-and nano-sized particles in mice were estimated and visualized by X-ray scanning analytical microscopy. The study indicated that the difference in chemical character had a greater effect than did the particle size. We predict that the X-ray scanning analytical microscopy will be a useful method for studying the biodistribution of micro-and nano-sized particles because this method requires no labeling or treatment of the target particles [413] .
The PIXE can even be used as a therapeutic tool because metallic NPs (MNPs) are able to release localized X-rays when activated with a high-energy proton beam. The exploitation of this phenomenon in the therapeutic irradiation of tumors was then investigated. The PIXE-based X-ray emission was directed at CT26 tumor cells in vitro , which were administered with either gold (average diameter 2 and 13 nm) or iron (average diameter 14 nm) NPs (GNPs or SNPs). It increased with the MNP solution concentrations over the range of 0.1 -2 mg ml -1 . An in vivo study in CT26 mouse tumor models with tumor regression assay demonstrated a significant tumor dose enhancement, thought to be a result of the PIXE effect when compared to the conventional proton therapy (PT) without MNP (radiation-only group). Mice, which received GNP or SNP injection doses of 300 mg kg -1 body weight before proton beam therapy, exhibited from 75 % to 90 % tumor volume reduction (TVR) in the 20-day post-PT, while the radiation-only group showed only 18 % TVR and regrowth of tumor volume after the same timing. This approach may result in new treatment options for the infiltrative metastatic tumors and other diffuse inflammatory diseases (Figure 9 ) [414] .
In some situations under investigation, the use of complementary PIXE and RBS facilities allows information to be obtained at a high level of detail, yielding a new understanding of the affected tissues and the progression of disease [406, 415] .
The methods can produce quantitative distributions of the chemical elements obtained by combining PIXE with the other ion beam techniques, RBS, and STIM, even if STIM is also used by itself [416, 417] .
The RBS is then used for sample mass normalization of PIXE signal as it provides the quantitative determination of the different elements in biological samples. The accurate concentration of the chemical elements requires the determination of the initial mass of the sample done by STIM analysis [411, 418 -420] . As an example, the visualization of the penetration of sunscreen formulations containing TiO 2 NPs (about 20 nm primary particle size) into hair follicles of both the human and porcine skin using these complementary methods of ion microscopy (PIXE, RBS, STIM) showed that the NPs were found as deep as approximately 400 μ m in the follicle, obviously introduced mechanically rather than by a diffusive process ( Figure 10 ) [418] . Figure 10 shows a sagittal cut through a hair follicle of porcine skin that was exposed to an isopropylmyristate gel containing TiO 2 NPs and subsequently washed with water. The PIXE maps for P (red), S (green), and Ti (blue) are superimposed. The Ti is clearly observed on top of the stratum corneum as well as in the follicle surrounding the hair. The left and right images are identical with the Ti color code overmodulated to better visualize the Ti spots.
More recent studies have used the high-resolution nuclear microprobe to investigate the interaction of metal oxide NPs with the cells and multicellular organisms (Figure 11 ). Up to now, the nuclear microprobe still lacks the sufficient spatial resolution to resolve individual NPs, but permit to determine and detect, track, and quantify the metal oxide NP aggregates and to assess the effect of the NPs on trace element homeostasis, such as calcium [421, 422] .
Another promising research area is the study of the intracellular localization of the functionalized NPs by combining in vivo optical/epifluorescence imaging and high-resolution PIXE/RBS/STIM analysis ( Figure 12 ) [423] .
We can predict that the X-ray scanning analytical micro scopy will be a useful method in studying the biodistribution of the micro-and nano-sized particles because this method requires no labeling or treatment of the target particles.
Multimodal bioimaging
Multimodal techniques and instrumentation
Multimodal bioimaging became possible not only because of the multimodal NPs [424] but also because of the development of the adapted techniques capable of combining two or even three types of the analysis in a single machine. The MRI/PET probes [35] , for example, are powerful emerging tools, combining the sensitive, metabolically functional PET with the high-resolution, anatomical detail provided by MRI. They had a real expansion with the development of the MR/PET scanner [425 -427] . This is not the only example, and this domain of multiple modality techniques will most likely go on growing in the future [90, 172] .
The improvement in instrumentation and detection systems is also a crucial point enhancing the sensitivity of these emerging imaging techniques. The improved imageanalysis software and expanded data storage can make the existing technologies even more powerful.
Multimodal nanoprobes
The imaging modalities in the clinic generally include optical imaging, MRI, CT, US, and PET or SPECT. A current popular approach to overcome their specific limitations results in combining two or more CAs into a single NP entity, which can then be imaged by these multiple techniques either consecutively or simultaneously depending on the degree of development of the techniques [19, 171, 199 -201, 281, 383, 428 -438] . Combining the anatomical resolution of MRI with the sensitivity of optical imaging is common and constitutes a powerful technique for finding and quantifying the size of tumors, especially the tumors or metastases that are too small for MRI detection alone. These MR/optical imaging agents can be used to monitor enzyme activity, in brain tumor imaging, and to detect and monitor apoptosis and atherosclerosis [439] . The other types of multimodal CAs [5, 25, 74, 200, 201, 281, 430, 432, 433, 436, 437, 440 -442] , such as the probes with three modes of imaging are considered, for example, MRI/NIRF/PET [439] , and even four [425, 439, 443, 444] , which are gathered in Table 3 . As an example, the difficulty in delineating brain tumor margins is a major obstacle for further efficient treatment [461] . The current imaging methods are often limited by inadequate sensitivity, specificity, and spatial resolution. To overcome this issue, Kircher et al. recently showed that a unique triplemodality MRI/PAI/Raman imaging NP (MPRNPs) could accurately help delineate the margins of brain tumors in living mice both in preoperative and intraoperative ways. The probes were detected by all three modalities with a picomolar sensitivity both in vitro and in living mice. The IV injection of MPRs into glioblastoma-bearing mice led to MPRNP accumulation and retention only by the tumors. This provided noninvasive tumor delineation by the three modalities and through the intact skull. Raman imaging helped for the guidance of intraoperative tumor resection because it could accurately delineate the tumor margins.
All these combinations are expected to provide very precise and detailed information for clear diagnosis and to be more efficient than a single modality. However, it should be stated that the rational selection of the different imaging modalities to put on a single probe is highly crucial. During the design of these multimodal imaging probes, the enhancement of one modality must not be at the expense of another, and researchers should rationally avoid the overlapping of the advantages and rather compensate for the weak points of each modality so as to maximize the overall synergistic effect. Generally, the imaging modalities with high sensitivity (PET, optical, etc.) are combined with the others, which will exhibit high spatial resolution (MR, CT, etc.) (Table 1 ) .
Furthermore, these bioimaging techniques require different administered doses, based on the technique ' s sensitivity, host biology, route of delivery, and the targeting strategy used. The controlling of the ratios of the different types of agents on a single probe becomes compulsory so as to obtain the perfect SNR for each modality. Additionally, the incorporation of more than one modality may cause interferences between the two, iron-based MRI agents quenching fluorescence agents, for example, and complicate the synthetic aspect. Succeeding in this approach would lead to the administration of a single dose of multiple agents to the patient, resulting in a potential reduction of the side effects.
Functionalization
Most disease processes occur at the molecular and cellular levels; therefore, the researchers have to face a breakthrough in precisely viewing and understanding these processes. The ideal imaging resolution they want to reach is a few nanometers, the length scale of most biological levels. With this in mind, the functionalization of the NPs becomes crucial for their use in diagnostic and therapeutic applications. The research on the functionalization of the NPs for bioimaging applications has been reviewed [25, 98, 360, 465 -471] . The preparation of the NPs for bioimaging applications can include a variety of steps: synthesis, coating, surface functionalization, and bioconjugation. The most common strategies of engineering NP surfaces involve physical adsorption or chemisorption of the desired ligands onto the surface. Chemisorption or covalent linkages are preferred, and the coated NPs should possess high colloidal stability, biocompatibility, water solubility, as well as functional groups for further bioconjugation. The functionalization techniques reported in the literature suffer from limitations such as complex synthesis steps, poor biocompatibility, low stability, and hydrophobic products. Therefore, the coating strategies based on chemisorption and ligand exchange often provide a better way to finely tune the surface properties of NPs. After conjugation with the appropriate targeting ligands, antibodies, or proteins, fluorescent NPs also exhibit highly selective binding, making them useful for targeting and imaging (Table 4 ) [465] .
The synthesis of the NPs leads to two major categories: hydrophobic and hydrophilic NPs, respectively. Many NPs, mainly QDs and metal NPs are hydrophobic Regardless of the composition, the surface functionalization of the nanomaterial is required to enable targeting and stealth for long circulation times with minimal nonspecific binding [239] . There is a plethora of entities that can be incorporated onto a NP ' s surface, with covalent bonding preferred over electrostatic interactions: DNA, RNA [472] , oligonucleotides (aptamers) [29, 434, 473 -476] , peptides [36, 175, 201, 477 -482] , proteins [483 -487] , enzymes [488 -491] , and antibodies [492] . No matter what the surface moiety is, its activity must not be altered once anchored to the NP surface ( Figure 13 ).
The routes of delivery and bioavailability are also important concerns in which functionalization is crucial. The most common delivery route is IV injection, which requires an optimization of the NP circulation time as they must be able to pass through the bloodstream and reach their desired target intact. Their surface functionalization generally results in size increase due to the added shell (silica, PEG, poloxamines, poloxamers, polysaccharides). This size increase may be detrimental for vasculature permeability and may affect the bloodstream circulation especially through the thin capillaries.
In addition to IV administration, intramuscular injections, oral, transdermal, and inhalation routes are also possible, and the NPs must be able to survive their particular delivery route. The probe, to be effective, must perform the desired function or bind properly to the desired target so that any loss of biological activity of the component conjugated to the NP surface must be determined beforehand.
Functionalization can also help in addressing NP toxicity aspects [12, 354, 358, 465, 468, 493, 494] . Indeed, properly protected NPs, conjugated or coated with biocompatible materials, can be used for the fabrication of various functional systems with multimodality as well as targeting properties, reduced toxicity, and proper removal from the body.
Furthermore, the governmental institutions should require a standardization process of NP characterizations (as particle size, shape, dissolution rate, agglomeration state, and surface area and chemistry) [495] as well as toxicity assays. It has generally been assumed that in vitro toxicity tests designed for the soluble chemicals are appropriate for the nanomaterials. However, the extrapolation of in vitro toxicology findings to humans is not so obvious when the mode of action and/or metabolic conditions in the cell culture model may not be relevant in humans [496 -498] . This is not an easy task, as the standardized established tests should work for multiple particle types, despite the fact that these NPs have different characteristics and behaviors (fluorescence, magnetism, metallic nature … ), but it should definitely be undertaken. When such NPs are used in bioimaging, it is also crucial to have an accurate characterization to fully understand (i) their structure-function relationship such as particle number and dose administered so as to make the right balance between safety and good SNRs, (ii) their behavior in the biological environment (e.g., dispersibility or aggregation), and (iii) the interactions between the functionalized surface of the NP and the target of interest (i.e., binding kinetics and thermodynamics).
Perspectives: multimodal theranostic NPs
To successfully translate the multimodal NPs into clinical treatment, several issues have to be taken into consideration such as (i) reasonable blood half-life, (ii) favorable physiological behavior with minimal off-target, (iii) any possible metabolism to clearable components, (iv) effective clearance of NPs from the human body, and (v) their potential toxicity for living subjects and humans. So, when adequately modified, the multimodal nanoprobes can also become theranostic NPs. They are then essentially found in cancer research, where they provide the diagnostic capability using an imaging modality to detect a tumor, while supplying the component for therapy against this specific tumor type, commonly utilizing PTA or PDT. PTA works by exciting a NP with a large absorption cross section (e.g., gold), which causes a localized heating that then kills the tumor cells into which the NPs have been injected [337] . Once more, the gold-based nanoobjects are numerous: gold nanoshells and nanocages surrounding a silica core have been used in photo-ablative therapies [329, 345 -347, 356, 499 -503] even if PTA has also been used with SWCNTs [504] . PDT uses photosensitizers that, when excited by light, react with molecular oxygen in the biological environment to produce ROS, which are cytotoxic to cells. Multifunctional NPs used for multimodal imaging and theranostic applications have been reviewed [8, 126, 150, 388 -391, 416, 481, 505 -508] . One material that may prove useful in combining a dual imaging and therapy is mesoporous silica NPs; with their large surface areas and pore volumes, one or two modalities (optical imaging agent and an anticancer drug) can be incorporated into the silica matrix while loading the other modality into its pores [509 -511] .
Encapsulating drug payloads in NPs can prevent the exposure of healthy cells to the cytotoxic drug and may prove more beneficial (e.g., lower toxicity and fewer side effects) at lower doses than the free drug. However, this can be much more complex than the use of simple smallmolecule drugs that are easily characterized. In addition, the NP must remain intact until reaching the tumor site and then release the drug controllably through its desired mechanism -issues that will require further research and development.
Owing to their nanoscale dimensions and high aspect ratio, SWCNTs have been used as a high drug-loading transporter for anticancer drugs, as they are capable of penetrating the mammalian cell membranes. The triple functionalization of oxidized SWCNTs with the anticancer drug doxorubicin (DOX), a monoclonal antibody, and a fluorescent marker at noncompeting binding sites allowed for the targeted delivery of drug to the cancer cells and the visualization of their cellular uptake by confocal microscopy. An intracellular release of DOX was observed, which then translocated to the nucleus while the nanotubes remain in the cytoplasm [512] .
Other important areas in which multimodal NPs can be beneficial include (i) tumor imaging for guided surgery [323, 513 -516] , (ii) imaging of gene expression in vivo to elucidate disease development [287, 288, 296, 370, 517 -520] , drug delivery [471] , and (iii) efficacy of anticancer drugs [234, 337, 429, 498, 521 -525] .
In the near future, the NPs will not only be used as CAs to simply find and delineate tumors but also to aim at elucidating the biological processes and the cellular mechanisms so as to understand and hopefully cure other diseases than cancer, such as Alzheimer ' s, Parkinson ' s, multiple sclerosis, rheumatoid arthritis, and diabetes.
The major developments of the future should then concern the diagnosis as well as the treatment with therapeutic NPs. These new agents to be developed from a societal point of view will have to prove as highly superior to any currently existing system with the same function. Therefore, the development of CAs incorporating an additional functionality (i.e., therapeutic agent, measure of disease progression, or evaluation of treatment effectiveness) with the classical in vivo imaging modality will most likely be expanded, especially if based on some alreadyapproved material.
The additional types of NP CAs may see development in the future. These smart responsive probes that turn " on " or " off " when exposed to the target or given conditions are being developed. Two fluorochromes (Cy5.5) cleavable by proteases, and (Cy7) which serves as an internal standard, were grafted on superparamagnetic IONPs leading to a dual fluorochrome optical probe, which reacted to the presence of protease enzymes in its environment with a change in signal (700 % increase in fluorescence) [526] .
Tumor cells have a more acidic internal environment compared with normal cells (most cancer tissues have lower extracellular pH values (pH 6.0 -7.0) than normal tissues (pH 7.4), and the pH drops further in tumor cells, especially inside endosomes (4.5 -5.5), which provides a high possibility to control the drug-release behaviors through the use of pH-sensitive vehicles. Many systems exploiting this pH modification are under scrutiny [527] .
The well-defined core@shell (MCNC@PAA) nanospheres, based on a 100-nm-sized magnetic colloid nanocrystal cluster core and a cross-linked poly(acrylic acid) (PAA) shell were, for example, loaded with DOX. [528] The experimental results showed that (i) the MCNC@PAA NPS could achieve a high drug-loading content and entrapment efficiency, (ii) a synergistic pHresponsive effect derived from the entrapped DOX and PAA network was found to effectively manipulate the drug-releasing behavior at 37 ° C. In fact, the premature release was highly restricted at a pH of 7.4, while upon the more acidic ones (pH from 7.4 to 5.0 or 4.0), a large amount of the drug was rapidly released. The in vitro cellular cytotoxicity test proved that they are highly biocompatible and suitable for use as a drug carrier in CDDS and that MCNC/PAA-DOX show a higher cytotoxicity compared with that of the free DOX to HeLa cells. Other pH-sensitive-based NPs have been used such as chitosan [529] polymers [530] , core@shell NPs [527] , and nanogels [531] . Among the stimuli-sensitive NPs are the light-sensitive ones. For example, light-stimulated remote release of nucleic acid has been attempted by utilizing the tunable optical properties and moderating the Au-S bond strength of various gold nanomaterials [532, 533] . For example, the temporally and spatially controlled delivery of siRNA using NIR-sensitive gold nanoshell-siRNA conjugates was explored [534] . The pulsed NIR laser irradiation, after their easy cellular uptake by TAT-lipid attached on the gold nanoshell, triggered the siRNA release and resulted in the efficient gene silencing in vitro . A remote optical switch for the localized and selective control of the RNA interference was also achieved using gold nanorods conjugated with thiol-modified sense strand of double-stranded oligonucleotides [535] . Some of these NPs are dual probes with both photo-and pH-responsive properties [536] .
A recent review by Kwon et al. on the stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications came out in which they introduce the recent advances in tackling the key challenges in achieving an efficient, targeted, and safe nonviral gene delivery using various nucleic acid-containing nanomaterials that are designed to respond to various extra-and intracellular biological stimuli (pH, redox potential, and enzyme) as well as external artificial triggers (light and US). The nanomaterial platform for combined imaging and gene therapy, nanotheranostics, using stimuliresponsive materials, was also highlighted in this review. It is clear that developing novel multifunctional vectors, which transform their physicochemical properties in response to various stimuli in a timely and spatially controlled manner, is highly desired to translate the promise of gene therapy for clinical success. The temperature-sensitive NPs have been identified, many of them including heat activable iron oxide and thermosensitive polymers [537 -547] , silica NPs [542, 544, 548] , liposomes [548 -550] , micelles [551] , multifunctional NPs containing both CdTe QDs, and Fe 3 O 4 magnetic particles [552] .
These nanomaterial CAs will certainly find more than numerous applications as tunable, remotely controlled platforms for drug delivery, hyperthermia cancer treatment, and various other biomedical applications. The basis for the interest lies in their unique properties achieved at the nanoscale that can be accessed via remote stimuli. These properties could then be exploited to simultaneously activate the secondary systems that are not remotely actuatable [440, 535, 536, 553 -561] . Despite all the work already performed, Richard Feynman is still more than right: " There is still Plenty of Room at the Bottom. "
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